On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Featured in Benzinga Article Evaluating Potential of Cannabinoids in Treating Alzheimer’s

Company: India Globalization Capital, Inc. (IGC)
Category: News

On Thursday, India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, was featured in an article on Benzinga titled ‘Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work’. The article notes that soon after discovering the pathway by which low-dose THC binds to amyloid beta plaques and prevents them from aggregating on neurons, the University of South Florida filed a patent for that mechanism. Notably, IGC announced on June 12 that it had acquired exclusive rights to this patent, titled ‘THC as a Potential Therapeutic Agent for Alzheimer’s Disease’, positioning the company to protect a potential cannabis-based blockbuster treatment for America’s most expensive disease. “What IGC is going to do with this patent is take it to clinical trials,” Ram Mukunda, CEO of IGC, stated in the Benzinga article. “We have productized it, and there is more than sufficient evidence. So, now we are now talking to several different places to see where we can begin clinical testing on the path to FDA approval.” If FDA approval is achieved, the market potential for a THC-based Alzheimer’s treatment could be expansive. There are currently more than 5.3 million Americans living with Alzheimer’s, and Medicare and Medicaid alone are expected to spend $175 billion on Alzheimer’s patients in 2017.

To view the full Benzinga article, visit http://nnw.fm/K0JdW

About IGC

India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland. For more information visit www.igcinc.us

About NetworkNewsBreaks

NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217